A Non-pharmacological Cough Control Therapy

Launched by WEST PARK HEALTHCARE CENTRE · Feb 19, 2021

Keywords

ClinConnect Summary

This clinical trial is investigating a new therapy that does not involve medication to help control coughing in patients with interstitial lung disease (ILD). Coughing can be a major issue for people with ILD, causing physical discomfort and emotional distress, and it can make everyday activities, work, and social interactions difficult. Unfortunately, current medications for chronic cough have not been very effective and can cause side effects. This study aims to see if a non-drug therapy can help reduce coughing and improve the quality of life for patients with ILD who have been coughing for more than 8 weeks.

To participate, individuals must have a confirmed diagnosis of ILD and a chronic cough lasting more than 8 weeks. However, those with certain conditions or recent medical issues, such as a respiratory infection or significant sputum production, will not be eligible. Participants in this study can expect to engage in a therapy program alongside pulmonary rehabilitation, which is designed to help improve lung health. The trial is currently recruiting individuals aged 65 to 74 and those between 31 and 45, regardless of gender. This is a great opportunity for those struggling with chronic cough to potentially benefit from a new approach.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals will be included if having confirmed diagnosis of any ILD by a physician (as per Canadian Thoracic Society's guideline for evaluating patients with fibrotic interstitial lung disease) and a chronic cough lasting more than 8 weeks in duration
• Exclusion Criteria:
• • self-reports of moderate or large sputum production
• • effective or suspected exacerbation of the respiratory condition in the past month
• • upper respiratory tract infection in the past month
• • use of angiotensin-converting enzyme inhibitor medication
• • changes in the prescribed medication in the previous month
• • evidence of traction bronchiectasis in the HRCT
• • evidence of other medical conditions that prevent performance of an exercise training program
• • unable to read or speak in English / unable to provide informed consent.